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Abstract
Plasmodium sporozoites invade host hepatocytes and develop as liver stages (LS) before the onset of erythrocytic infection
and malaria symptoms. LS are clinically silent, and constitute ideal targets for causal prophylactic drugs and vaccines. The
molecular and cellular mechanisms underlying LS development remain poorly characterized. Here we describe a conserved
Plasmodium asparagine-rich protein that is specifically expressed in sporozoites and liver stages. Gene disruption in
Plasmodium berghei results in complete loss of sporozoite infectivity to rodents, due to early developmental arrest after
invasion of hepatocytes. Mutant sporozoites productively invade host cells by forming a parasitophorous vacuole (PV), but
subsequent remodelling of the membrane of the PV (PVM) is impaired as a consequence of dramatic down-regulation of
genes encoding PVM-resident proteins. These early arrested mutants confer only limited protective immunity in immunized
animals. Our results demonstrate the role of an asparagine-rich protein as a key regulator of Plasmodium sporozoite gene
expression and LS development, and suggest a requirement of partial LS maturation to induce optimal protective immune
responses against malaria pre-erythrocytic stages. These findings have important implications for the development of
genetically attenuated parasites as a vaccine approach.
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Introduction
With over 300 million cases each year, malaria remains the most
important vector-borne infectious disease, severely affecting human
health and social and economical development in endemic areas
[1]. The malaria parasite Plasmodium is transmitted via the bite of a
female Anopheles mosquito, which releases sporozoite stages into the
skin [2]. Sporozoites enter the blood stream and, upon reaching the
liver hepatocytes, transform into liver stages (LS), also called exo-
erythrocytic forms (EEFs). LS grow, undergoing multiple rounds of
nuclear divisions and ultimately produce thousands of first
generation merozoites, which then commence the development of
the pathogenic erythrocytic stages [3].
Plasmodium sporozoites invade hepatocytes by forming a
membrane-bound specialized compartment, the parasitophorous
vacuole (PV), where they differentiate into LS. LS are highly
metabolically active, undergoing one of the fastest growth rates
among eukaryotic cells. LS development is a complex process that
includes initial sporozoite transformation, remodeling of the PV
membrane (PVM), onset of mitotic divisions and parasite growth,
before eventual merozoite formation and egress. LS constitute
transition stages between sporozoites and merozoites, as reflected
on transcriptome and proteome levels [4]. How the parasite
regulates its gene expression to accomplish this critical transition
phase remains elusive.
LS represent potential targets for causal prophylactic drugs and
vaccines. In particular, immunization with radiation-attenuated
parasites (RAPs) can induce sterile protection against sporozoite
infection [5]. The recent demonstration that genetically attenuated
parasites (GAPs) also confer protective immunity in mouse models
created a renewed interest in whole parasite vaccine approaches
against malaria [6,7,8]. Protective immunity induced by RAPs and
GAPs relies primarily on CD8+ T cell responses against infected
hepatocytes [9,10,11,12,13,14,15], but the antigenic specificity of
protective CD8
+ T cells is unknown.
Because of the high A/T nucleotide content of Plasmodium DNA,
many malarial proteins contain low complexity regions (LCR).
Interestingly, the composition of these LCR is biased towards an
over-representation of asparagines as compared to lysines,
although both share the same codon AT-richness, suggesting a
phenotypic selection [16]. Still, the role of asparagine-rich proteins
in Plasmodium remains unknown. Here we focused on a conserved
Plasmodium asparagine-rich protein that is specifically expressed in
sporozoites and early LS, and was therefore termed SLARP
(Sporozoite and Liver stage Asparagine-Rich Protein). Parasites
lacking SLARP develop normally in the mosquito and invade
mammalian hepatocytes as efficiently as wild type parasites.
Nevertheless, they are completely arrested at a very early step of
LS development, prior to remodelling of the PVM and onset of
nuclear divisions.
Results
SLARP/S22 encodes a conserved asparagine-rich protein
Plasmodium liver stages (LS) are amongst the least known stages
of the parasite life cycle. In an attempt to identify potential
PLoS Pathogens | www.plospathogens.org 1 June 2008 | Volume 4 | Issue 6 | e1000086candidate genes specifically expressed in pre-erythrocytic stages,
we previously used a suppressive subtractive hybridization screen
in P. yoelii, which enabled the identification of 25 S genes expressed
in sporozoites but not in blood stages [17]. One of these genes
(S22) encodes an asparagine-rich protein that, as shown below, is
specifically expressed in sporozoites and early/mid LS, and was
therefore termed SLARP (Sporozoite and Liver stage Asparagine-
Rich Protein). The SLARP gene and its genomic organization are
conserved among Plasmodium species, including P. falciparum
(PfSLARP/PF11_0480), P. vivax (PvSLARP/Pv092945), P. knowlesi
(PkSLARP/PKH_094440), P. yoelii (PySLARP/Genbank accession
no. EU579525) and P. berghei (PbSLARP/Genbank accession no.
EU579524). SLARP contains one large and two small exons,
encoding a 2940–3305 amino acids protein with no apparent
similarities to known proteins (Fig. 1). Remarkably, SLARP
protein contains large stretches of low complexity, making up
,40% of its sequence in P. falciparum and ,30% in P. berghei and P.
yoelii, with an overrepresentation of asparagine residues.
SLARP is expressed in sporozoites and early/mid LS
According to P. falciparum DNA microarray data, PfSLARP
transcripts are readily detected in sporozoites but not in blood
stages [18], consistent with the gene expression profiling in P. yoelii
[17]. We investigated the expression of SLARP in different stages of
the rodent parasite P. berghei using RT-PCR. SLARP transcripts
were found in salivary gland sporozoites, as observed with TRAP,
but were barely detectable in mosquito midgut oocysts (Fig. 2A).
Sequencing of the RT-PCR products confirmed the predicted
exon-intron gene structure (data not shown). SLARP expression
was also detected in early (24h) and mid (48h) LS developing in
vitro in HepG2 cells, but not in late LS (72h) (Fig. 2B). The final
maturation of P. berghei LS in vitro is characterized by the
appearance of detached infected cells, also called merosomes, in
the culture supernatants [19]. SLARP expression was not
detectable in merosomes, or in blood stages, whereas a control
transcript (P. berghei glyceraldehyde 3-phosphate dehydrogenase,
GAPDH) was detected throughout liver stage development
(Fig. 2B).
In order to confirm SLARP expression timing and determine the
subcellular localization of the protein, we generated a parasite line
expressing the endogenous copy of SLARP fused in frame at its 39
end to the coding sequence of the red fluorescent protein mCherry
[20] (Fig. 2C). Transfection was performed in P. berghei ANKA
parasites constitutively expressing GFP [21], leading to green
fluorescent parasites that express a red fluorescent SLARP
(PbSLARP/mCherry). Genotyping confirmed the desired integra-
tion event, and PCR on cDNA from PbSLARP/mCherry
sporozoites showed expression and correct splicing of the fusion
transcript (data not shown). We next assessed the expression of the
fusion protein in different stages of PbSLARP/mCherry parasites
by direct detection of mCherry fluorescence by confocal
microscopy. As predicted, no red fluorescence was detectable in
blood stages or oocysts of PbSLARP/mCherry parasites (data not
shown). In contrast, mCherry could be detected in sporozoites and
LS (Fig. 2D), in good agreement with the RT-PCR data. The
mCherry signal in PbSLARP/mCherry parasites was rather weak,
but was clearly distinguishable from background, and was not
observed in WT parasites (Fig. 2D). Interestingly, mCherry
fluorescence had a similar distribution as the Hoechst staining in
PbSLARP/mCherry parasites (Fig. 2D). Although we could not
determine precisely using confocal microscopy whether SLARP/
mCherry localizes inside the nucleus or at its periphery, our data
clearly indicate that the fusion protein associates with the parasite
nucleus. Closer examination of the PbSLARP primary structure
revealed two potential bipartite nuclear localization signals (NLS)
that are conserved in SLARP from other Plasmodium species and
may contribute to the nuclear localization of the protein (Fig. 1B).
Together our findings show that Plasmodium encodes a sporozoite
and liver stage-specific asparagine-rich protein that seems to
localize predominantly in the parasite nuclear region.
SLARP gene deletion in P. berghei
To study the importance of SLARP during the Plasmodium life
cycle, we generated loss-of-function P. berghei parasites. We used a
replacement strategy (Fig. 3A) to disrupt the endogenous SLARP
gene copy by double crossover homologous recombination [22]. A
targeting construct comprising 59 and 39 fragments of SLARP
flanking the pyrimethamine-resistance cassette was used for
positive selection after parasite transfection. The parental blood
stage population from a successful transfection was used to isolate
three independent disruptant clones, two of which were subse-
quently used for phenotypical analysis (slarp(-)cl1 and slarp(-)cl3).
Occurrence of the double crossover was confirmed by PCR in
pyrimethamine-resistant parasites, using primers specific for the 59
and the 39 end recombination events, respectively (Fig. 3B). The
wild type locus was not detected in slarp(-)cl1 and slarp(-)cl3,
confirming the homogeneity of the expected recombination. We
also performed RT-PCR on RNA from salivary gland sporozoites
of wild type and slarp(-) parasites. While TRAP control transcripts
were detected in all parasite populations, SLARP transcripts were
detected only in WT, but not in slarp(-) parasites, confirming the
successful depletion of SLARP in the mutants (Fig. 3C).
SLARP-deficient sporozoites are non-infective to rodents
We next examined the phenotype of slarp(-) parasites during the
P. berghei life cycle. As expected from successful disruption of the
SLARP gene in blood stages, slarp(-) clones were indistinguishable
from WT parasites in development and growth of asexual stages
(data not shown). slarp(-) parasites produced gametocytes and
exflagellation of male gametocytes was similar to WT parasites
Author Summary
Plasmodium parasites, the causative agents of malaria,
have a complex life cycle that alternates between a
mosquito vector and a vertebrate host. Infected mosqui-
toes transmit Plasmodium forms called sporozoites, which
rapidly migrate to the host liver, invade hepatocytes, and
differentiate into replicative liver stages (LS). After inten-
sive multiplication, LS release merozoites that invade
erythrocytes and cause malaria symptoms. Plasmodium
LS are clinically silent, and represent ideal targets for
prophylactic antimalarial drug and vaccine interventions.
However, the molecular mechanisms underlying LS
development remain poorly characterized. We describe
here a Plasmodium protein, termed SLARP, which is
specifically expressed in sporozoites and LS. In the absence
of SLARP, sporozoites invade host cells normally but are
then completely arrested at a very early stage of LS
development. Our results indicate that SLARP functions as
a specific regulator of the expression of genes involved in
LS replication. Interestingly, early arrested SLARP-deficient
parasites confer only limited protection in immunized
mice, suggesting a requirement of parasite maturation to
induce optimal protective immune responses against LS.
Our study provides new insights into gene expression
regulation during the complex life cycle of the malaria
parasite and has important implications for the design of
vaccines targeting Plasmodium liver stages.
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and oocyst development were also normal when compared to WT
parasites. slarp(-) oocysts produced sporozoites, which invaded
mosquito salivary glands as efficiently as WT parasites (Table 1).
Based on these findings we conclude that SLARP is dispensable for
the P. berghei life cycle in the mosquito.
We further investigated slarp(-) sporozoite in vivo infectivity to
highly susceptible young Sprague-Dawley rats and C57BL/6
mice. In contrast to WT sporozoites, which consistently induced
blood stage infection, none of the animals inoculated with slarp(-)
sporozoites developed a patent blood stage infection, even after
intravenous injection of very high numbers of sporozoites (up to
500,000), or when sporozoites were inoculated through mosquito
bites, the natural transmission route (Table 2). These data
demonstrate that disruption of SLARP in P. berghei abolishes
sporozoite infectivity to rodents.
Depletion of SLARP results in early developmental arrest
after sporozoite invasion
Combined with the absence of a defect in blood stage
multiplication, the lack of infectivity of slarp(-) sporozoites
suggested a defect in sporozoite invasion and/or LS development.
To distinguish which step was affected, we analyzed slarp(-)
sporozoite infection in vitro in HepG2 cells. Sporozoites invade host
cells by two alternative routes, cell traversal or productive infection
[23]. Cell traversal is associated with host cell membrane rupture
followed by sporozoite migration through the host cell cytoplasm,
and is required for sporozoite migration in the skin and through
the liver sinusoidal barrier [24,25,26,27]. Productive infection of
hepatocytes requires the formation of a PV, in which LS
development takes place [23]. We analyzed these two different
invasion modes in vitro with WT and slarp(-) sporozoites. As shown
using a dextran-based wound and repair assay [23], cell traversal
activity was not impaired in slarp(-) parasites, with similar numbers
of dextran-positive cells as observed with WT (Table 1). The
number of intracellular sporozoites early after infection was similar
in slarp(-) clones and WT (Fig. 4A and Table 1), and most
sporozoites of WT (81,9+/20,4%, n=204) and slarp(-) (81,5+/
20,8%, n=211) were found in dextran-negative cells, providing
indirect evidence that slarp(-) sporozoites are capable of produc-
tively entering the host cell. Staining with the cholesterol-binding
agent filipin [28] confirmed the presence of a PVM in both WT
and slarp(-) sporozoite-infected cells (see Fig. 5A–B).
The number of WT LS in the cultures was constant from 6 until
48 hours post-infection, followed by a marked decrease at
72 hours (Fig. 4A), which was concomitant with the appearance
in the culture supernatants of detached infected cells (merosomes).
Morphologically, WT parasite development was characterized by
an increase in size over time and the occurrence of multiple
nuclear divisions, as shown by Hoechst staining (Fig. 4B and 4C).
Figure 1. SLARP is conserved in Plasmodium species. (A) Genomic organization of representative Plasmodium SLARP genes. Shown are the SLARP
gene loci for P. falciparum (PfSLARP/PF11_0480), P. vivax (PvSLARP/Pv092945), P. knowlesi (PkSLARP/PKH_094440), P. yoelii (PySLARP/PY03269,
PY03923, Genbank accession no. EU579525) and P. berghei (PbSLARP/PB000542.00.0, PB000547.01.0, Genbank accession no. EU579524). Sequence
identity of the corresponding gene products are displayed on the right in comparison to PfSLARP. (B) Alignment of the C-terminal end of Plasmodium
SLARP proteins. Conserved residues are shaded in grey. The boxes indicate potential nuclear localization sequences (NLS) identified with PSORT II
(http://psort.nibb.ac.jp).
doi:10.1371/journal.ppat.1000086.g001
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culture monolayers displayed the typical aspect of mature
segmented parasites (Fig. 4B). In contrast to WT parasites, the
number of slarp(-) LS decreased over time in vitro, and we did not
observe detachment of infected cells and release of merosomes
(Fig. 4A). Furthermore, slarp(-) LS remained very small throughout
the culture time, around 3–4 mm, which roughly corresponds to the
size of 12–18h WT parasites (Fig. 4B). Most slarp(-) parasites were
blocked at the one nucleus stage, evenat late time points of infection
(Fig. 4C). Notably, nuclear material was no longer detectable in a
significant proportion of the mutant parasites, and this proportion
increased over time (Fig. 4C). Taken together, these results
demonstrate a severe defect of parasite replication in SLARP-
deficient LS, which do not survive in vitro.
Remodelling of the PVM is impaired in SLARP-deficient
parasites
The early post-invasion defect of LS development and the
PVM-positive filipin stain observed in slarp(-) parasites prompted
us to analyze the expression of the up-regulated in infective
sporozoites (UIS)-4 protein, which specifically localizes to the
PVM early after invasion [6]. Invaded WT sporozoites displayed a
strong UIS4 staining that extended to the host cell cytoplasm and
colocalized with filipin (Fig. 5A), consistent with PVM localiza-
tion. Importantly, no UIS4 or filipin staining of sporozoites was
observed in infected dextran-positive cells (Fig. 5A). This confirms
that UIS4 and filipin are specific markers of PVM formation, and
further suggests that the bulk of UIS4 found in intracellular
parasites is synthesized after sporozoite productive invasion.
Remarkably, although slarp(-) sporozoites formed a PV inside host
cells, as demonstrated by the absence of dextran uptake by the host
cell and by staining of sporozoites by filipin, they lacked peripheral
UIS4 staining (Fig. 5A–B). Instead, only weak internal UIS4
staining was sometimes observed in the mutant parasites, which
likely corresponds to residual protein originating from sporozoites.
We also analyzed expression of the Exported Protein-1 (EXP1), a
mid/late LS antigen initially not present in sporozoites but
expressed in LS, where, like UIS4, it localizes to the PVM
[19,29,30]. EXP1 was detected by immunofluorescence in WT
LS, with a circumferential staining consistent with PVM
localization (Fig. 5C). As expected, EXP1 was not detected by
immunofluorescence in salivary gland sporozoites or intracellular
Figure 2. SLARP is expressed in P. berghei sporozoites and early/
mid LS. (A) RT-PCR analysis of SLARP and TRAP expression in mosquito
midgut (MG) and salivary gland (SG) sporozoites. gDNA, genomic DNA;
+, with reverse transcription; 2, without reverse transcription (B) RT-PCR
analysis of SLARP and GAPDH expression in early (24 hours), mid
(48 hours) and late (72 hours) LS, merosomes (recovered from the
culture supernatants 72 hours post-infection), and mixed blood stages
(BS). gDNA, genomic DNA; +, with reverse transcription; 2, without
reverse transcription. (C) Insertion strategy to generate the SLARP/
mCherry parasites. The PbSLARP genomic locus was targeted with an
integration plasmid containing a 39 terminal fragment of the SLARP
gene fused in frame to the mCherry coding sequence (M), the 39 UTR of
PbDHFR/TS (39UTR) and the TgDHFR/TS selectable marker. Upon a single
crossover event, the region of homology is duplicated, resulting in a
functional, endogenous PbSLARP copy tagged with mCherry, followed
by a truncated and non-expressed copy. (D) Detection of the SLARP/
mCherry fusion protein (red) was analyzed directly by confocal
fluorescence microscopy of sporozoites isolated from mosquito salivary
glands (SPZ), or intracellular parasites 2h30 and 24 hours post-infection
(p.i.) of HepG2 cells with SLARP/mCherry or WT P. berghei parasites
constitutively expressing GFP (green). Nuclei were stained with Hoechst
33342 (blue). Bar=5 mm. Note that the red fluorescent structures
(indicated by asteriks) observed around SLARP/mCherry or WT parasites
were also found in non-infected HepG2 cells, and correspond to host
autofluorescent material unrelated to mCherry fluorescence (indicated
by arrowheads), which was only observed inside SLARP/mCherry (but
not WT) parasites.
doi:10.1371/journal.ppat.1000086.g002
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with WT parasites, we consistently failed to detect EXP1 in slarp(-)
LS (Fig. 5C–D).
Deletion of SLARP causes a dramatic decrease of UIS3 and
UIS4 transcript abundance in sporozoites
In order to determine whether the absence of UIS4 protein in
invaded sporozoites was due to a defect in UIS4 gene expression,
we analyzed steady state transcript abundance in slarp(-) versus
WT parasites, using quantitative PCR (RT-qPCR). We observed a
dramatic reduction (,80 fold) of UIS4 transcript abundance in
Figure 3. Targeted gene disruption of P. berghei SLARP. (A)
Replacement strategy to generate the slarp(-) parasites. The wild-type
(WT) PbSLARP genomic locus was targeted with a SacII/KpnI-linearized
replacement plasmid containing 5’ and 3’ regions of the SLARP open
reading frame (ORF) and the Toxoplasma gondii dhfr/ts-positive
selectable marker. Upon a double crossover event, the SLARP gene is
replaced by the selectable marker. Replacement- and wild type- specific
test primer combinations and expected fragments (test1; test2; wt) are
indicated. (B) Replacement-specific PCR analysis. Confirmation of the
predicted gene targeting is achieved by specific primer combinations
(test 1 and test 2), which can only amplify a signal from the
recombinant locus. A wild type-specific PCR reaction confirms the
absence of residual wild-type parasites in the clonal slarp(-) populations.
(C) Depletion of SLARP transcripts in slarp(-) parasites. cDNA from wild-
type and slarp(-) salivary gland sporozoites was amplified by PCR. Note
the absence of a SLARP–specific signal in slarp(-) clones compared to a
control transcript (TRAP), confirming the successful depletion of SLARP.
doi:10.1371/journal.ppat.1000086.g003
Table 1. P. berghei slarp(-) sporozoites invade mosquito
salivary glands and mammalian hepatocytic cells.
Parasite
population
Number of salivary
gland sporozoites
per mosquito
a
Transmigration
(% dextran-
positive cells)
b
Host cell
invasion
(Number of
sporozoites)
c
Wild type 10,486+/21233 7.3+/21.1 531+/2152
slarp(-) cl1 10,926+/2370 4.9+/20.7 469+/267
slarp(-) cl3 11,185+/21153 5.7+/20.7 453+/2100
aThe mean number (+/2SD) of sporozoites was determined at day 19 after the
infectious blood meal from at least three independent feeding experiments.
bThe mean percentage (+/2SD) of dextran positive cells was determined by
FACS analysis 3 hours after adding sporozoites to HepG2 cells.
cThe mean number (+/2SD) of invaded sporozoites was determined by IFA
6 hours after addition of sporozoites to HepG2 cells.
doi:10.1371/journal.ppat.1000086.t001
Table 2. P. berghei slarp(-) sporozoites are not infective to
rodents.
Animals
Parasite
population Inoculum
a
Number of
infected
animals
Prepatency
(days)
b
SD rats Wild type 1,000 2/2 4
10,000 2/2 3,5
mosquito bites 2/2 4,5
slarp(-) cl1 1,000 0/4 NA
10,000 0/4 NA
mosquito bites 0/4 NA
C57BL/6
mice
Wild type 1,000 2/2 4
10,000 4/4 3
100,000 4/4 3
mosquito bites 3/3 3,3
slarp(-) cl1 1,000 0/4 NA
10,000 0/4 NA
100,000 0/4 NA
slarp(-) cl3 10,000 0/16 NA
50,000 0/10 NA
250,000 0/2 NA
500,000 0/1 NA
mosquito bites 0/5 NA
aAnimals were injected intravenously with indicated numbers of sporozoites or
exposed to the bites of 5–10 infected mosquitoes days 18–21 after the
infectious blood meal.
bNumber of days after sporozoite inoculation until detection of infected
erythrocytes by microscopic blood smear examination.
NA: not applicable.
doi:10.1371/journal.ppat.1000086.t002
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infection, while control transcripts for GAPDH and heat shock
protein 70 (HSP70) were not affected (Fig. 6A). RT-qPCR also
demonstrated a ,20 fold reduction in the level of transcripts for
UIS3, another PVM-resident protein [7,13], whereas EXP1
expression was only slightly reduced (,2 fold) (Fig. 6A).
Although UIS3 and UIS4 are required only during LS
development, both are highly expressed already at the sporozoite
stage [6,7,13,31,32]. UIS4 protein could be detected in slarp(-)
sporozoites by immunofluorescence, but the labelling was
consistently less intense than in WT sporozoites (Fig. 6B).
Furthermore, RT-qPCR demonstrated a ,20 fold decrease of
UIS4 transcript abundance in slarp(-) salivary gland sporozoites
(Fig. 6C). As observed with invaded parasites, expression of UIS3
and EXP1 was also reduced in slarp(-) sporozoites collected from
infected mosquito salivary glands, although to a lesser extent (,3
fold and ,2 fold, respectively) (Fig. 6C). Importantly, expression
of several other genes was not significantly altered, including
HSP70 and genes involved in sporozoite invasion (TRAP and
apical membrane antigen-1, AMA1) or transmigration (sporozoite
protein essential for cell traversal, SPECT)( Fig. 6C). Altogether
these results demonstrate that the lack of SLARP causes a selective
and severe defect in expression of sporozoite genes involved in
subsequent LS development.
Immunization with SLARP-deficient sporozoites confers
limited protective immunity against P. berghei infection
in C57BL/6 mice
Several studies have demonstrated that immunization with
GAPs can induce protective immune responses against sporozoite
infection in mice [6,7,8,13,33]. Because genetic attenuation offers
several advantages, notably in terms of reproducibility and stability
of attenuation, GAPs constitute an interesting alternative for whole
parasite vaccine approaches [34]. One essential requirement for a
malaria GAP-based vaccine is the absence of breakthrough
infections caused by the parasites used for immunization. Since
slarp(-) sporozoites never cause blood stage infections (Table 2),
they make interesting candidates as GAP vaccines. To test whether
SLARP-deficient parasites are capable of inducing protective
immunity, we immunized C57BL/6 mice with different doses of
slarp(-) sporozoites, administered either by intravenous injection or
through exposure to infective mosquito bites. Mice immunized
with 50,000 slarp(-) sporozoites followed by two boost injections of
25,000 sporozoites were fully protected when challenged with WT
parasites 6 weeks after the last boost (Table 3). However,
protection rapidly decreased over time, since challenge 16 weeks
after the last boost resulted in 40% protection only (Table 3).
Reducing the dose of sporozoites used for immunization led to a
progressive loss of protection. Sterile protection was only achieved
in some of the mice immunized with 10,000 slarp(-) sporozoites,
with a ,2 days delay in patency in non-protected animals as
Figure 4. slarp(-) parasites are impaired in liver stage develop-
ment. (A) HepG2 cells were infected with WT or slarp(-) sporozoites
(1610
4) and cultured for 6–72 hours before staining with anti-CSP or
anti-HSP70 antibodies and quantification by fluorescence microscopy.
Results are expressed as the mean number of parasites from triplicate
wells+/2SD. DC, detached infected cells. (B) HepG2 cells were infected
with WT or slarp(-) sporozoites and cultured for 24, 48 or 72 hours
before staining with anti-HSP70 antibodies (green) and Hoechst 33342
(blue), and examination by confocal fluorescence microscopy.
Bar=10 mm. (C) HepG2 cells were infected with WT or slarp(-)
sporozoites and cultured for 24, 48 or 72 hours before staining with
anti-HSP70 antibodies and Hoechst 33342. For each population, the
number of nuclei in at least 50 parasites was determined by
examination under a fluorescence microscope.
doi:10.1371/journal.ppat.1000086.g004
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parasites in the liver (Table 3). No protection was observed in the
groups immunized with 1,000 slarp(-) sporozoites or by mosquito
bites, where all mice developed a blood stage infection after
challenge, with only a minor delay in patency as compared to
naı ¨ve mice (Table 3).
Discussion
Parasite replication in the liver is a prerequisite for the onset of
malaria blood stage infection. Still, Plasmodium LS development
remains poorly characterized on a molecular level. In this study,
we identified a Plasmodium nuclear protein that is specifically
expressed in sporozoites and LS and is vital for LS development.
The developmental arrest observed in slarp(-) parasites is
reminiscent of axenically cultured sporozoites that undergo initial
transformation from elongated sporozoites to round early LS but
fail to enter mitosis [35]. We hypothesize that this fundamental
developmental switch is regulated, at least partially, by SLARP.
Our results demonstrate that the lack of SLARP causes a
complete developmental arrest after sporozoite invasion. This
phenotype is strikingly different from sporozoite gene knockouts
reported so far [6,7,8,26,27,36,37,38]. Slarp(-) sporozoites produc-
tively enter target cells under simultaneous formation of a
replication-competent organelle, the PV. However, remodelling
of the PVM is impaired as illustrated by the absence of two PVM-
resident proteins, UIS4 and EXP1, in mutant parasites. It is
unlikely that the defect in UIS4 expression alone is the cause for
the developmental arrest observed in SLARP-deficient parasites.
Indeed, LS development is not completely blocked in UIS4-
knockout parasites, as evidenced by partial growth in vitro and
occurrence of blood stage infections after sporozoite inoculation
[6]. We rather hypothesize that defects in expression of multiple
LS proteins (including UIS4, UIS3 and EXP1) account for the
severe phenotype observed with slarp(-) parasites.
Regulation of gene expression in Plasmodium is poorly under-
stood. Based on the paucity of specific transcription factors
identified in Plasmodium genomes and on comparative analysis of
transcriptome and proteome data, it was suggested that post-
transcriptional mechanisms may play a major role in regulation of
gene expression in Plasmodium [18,39,40,41,42]. In this regard,
translation repression was recently documented in sexual stages of
the Plasmodium life cycle [43], and may as well occur in other stages
of the parasite life cycle. Nevertheless, the recent discovery of an
Apetala-2 (AP2)-related family of transcription factors in Plasmo-
dium raises the possibility that additional yet unidentified
transcription regulators are also involved [44].
Several lines of evidence strongly support a role for SLARP in
the regulation of gene expression in sporozoites and early LS. First,
SLARP is expressed in sporozoites and early/mid LS, as shown by
RT-PCR, and a tagged version of SLARP fused to the red
fluorescent protein mCherry localizes predominantly to the
Figure 5. Remodelling of the PVM is impaired in SLARP-deficient parasites. (A) HepG2 cells were infected with WT or slarp(-) sporozoites in
the presence of FITC-dextran and cultured for 6 hours before staining with anti-CSP (green), anti-UIS4 (red) and filipin (blue), followed by analysisb y
confocal fluorescence microscopy. Bar=5 mm. Note that sporozoites inside dextran-positive cells were not stained by anti-UIS4 or filipin. (B) The
percentage of UIS4 and filipin stained sporozoites was determined by examination of at least 50 dextran-negative infected cells for each population.
(C) HepG2 cells were infected with WT or slarp(-) sporozoites and cultured for 48 hours before staining with anti-HSP70 (green) and anti-EXP1 (red)
antibodies and analysis by confocal fluorescence microscopy. Bar=10 mm. (D) The percentage of HSP70 and EXP1 labelled parasites was determined
by examination of at least 50 GFP-positive 48h LS for each population.
doi:10.1371/journal.ppat.1000086.g005
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be required to determine whether this nuclear localization of
SLARP/mCherry reflects the normal distribution of the endog-
enous SLARP, or represents an artefact resulting from the fusion
to mCherry. We favor the former, since NLS are present in
SLARP but not mCherry protein sequence, and various other
parasite lines with different mCherry tagged proteins generated in
our lab do not display nuclear localization of the fusion protein
(E.D. Putrianti, O. Silvie and K. Matuschewski, unpublished data).
Second, we demonstrate here using quantitative PCR that deletion
of SLARP causes a dramatic decrease in steady state transcript
abundance for at least two genes, UIS3 and UIS4, in sporozoites
collected from infected mosquito salivary glands or from HepG2
cells early after infection. This defect at the transcript level
correlates with a dramatic reduction of the UIS4 protein content
in invaded sporozoites, and to a lesser extent in salivary gland
sporozoites, as shown by immunofluorescence.
Although UIS3 and UIS4 are essential only during LS
development, they are highly expressed at the sporozoite stage
[6,7,31,32], suggesting that sporozoites in the mosquito salivary
glands are already prepared for the next LS developmental step.
Similarly to UIS3 and UIS4, SLARP is expressed both in
sporozoites and LS. While expression of UIS3 and UIS4 is
dramatically diminished in slarp(-) parasites, expression of other
sporozoites genes, involved in host cell traversal or productive
invasion, is not affected, in good agreement with the absence of
phenotypical defect during transmigration or host cell invasion by
SLARP-deficient sporozoites. Based on these observations and the
early developmental arrest of slarp(-) LS, we propose that SLARP
functions as a specific regulator of the expression of genes involved
Figure 6. UIS3 and UIS4 gene expression is dramatically reduced in SLARP-deficient parasites. (A) Quantitative RT-PCR analysis of gene
expression in infected HepG2 cell cultures, 6 hours post-infection with WT or slarp(-) sporozoites. Relative gene expression was normalized to the GFP
expression level, and is expressed as the log2 of the ratio slarp(-)/WT (mean of three independent experiments+/2SD). (B) Air-dried WT and slarp(-)
salivary gland sporozoites were stained with anti-UIS4 antibodies (red) before examination by confocal fluorescence microscopy, using the same
settings as in Fig. 5A. Bar=5 mm. (C) Quantitative RT-PCR analysis of gene expression in slarp(-) salivary gland sporozoites. Relative gene expression
was normalized to the GFP expression level, and is expressed as the log2 of the ratio slarp(-)/WT (mean of three independent experiments+/2SD).
doi:10.1371/journal.ppat.1000086.g006
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probably additional yet unidentified genes.
The absence of EXP1 protein in slarp(-) LS probably involves a
distinct mechanism, different from that responsible for UIS4 (and
UIS3) depletion. First, EXP1 is expressed in blood stages, whereas
SLARP is not, demonstrating that SLARP is not required for
EXP1 expression. Second, our data show that abundance of EXP1
transcripts is only moderately affected in slarp(-) salivary gland as
well as early invaded sporozoites. The fact that the protein EXP1
is not detected in sporozoites and very early LS (despite transcript
presence) in WT parasites raises the possibility that EXP1
expression is regulated through post-transcriptional mechanisms.
Since the lack of SLARP has only a modest effect on the
expression of the EXP1 gene, as evidenced by quantitative RT-
PCR, we believe that the absence of EXP1 protein in slarp(-)
parasites probably reflects an early blockage in the LS develop-
mental program at a step that precedes the onset of EXP1
translation activation. The lack of UIS4, which like EXP1 resides
in the PVM, is probably not the cause of the defect in EXP1
expression in slarp(-) parasites since uis4(-) LS express EXP1 on
their PVM normally [13].
So far, we cannot ascertain whether SLARP directly modulates
UIS3 and UIS4 transcriptional level or is involved in upstream
events that govern UIS3 and UIS4 gene expression. Although
SLARP is characterized by a high content in asparagine residues,
a feature shared by most Plasmodium AP2 putative transcription
factors [44], as well as transcription regulators in other systems
such as yeast [45], it does not contain any known conserved DNA
binding domain. Whether SLARP acts as a specific transcription
factor or regulates the activity of a specific transcription factor is
still unknown. Alternatively, we cannot exclude that SLARP
regulates sporozoite gene expression by other mechanisms, such as
chromatin level regulation or post-transcriptional control.
Altogether our results demonstrate that SLARP is a key
regulator of Plasmodium LS development, and plays a critical role
in gene expression regulation at an early step of the infection
process. The identification of an asparagine-rich protein as a
master regulator of LS development raises the possibility that other
uncharacterized LCR-containing proteins may play a similar role
in other stages of the parasite life cycle. This study opens new
perspectives for the elucidation of gene expression regulation
during the complex life cycle of the malaria parasite and for the
characterization of molecular mechanisms of parasite development
inside host cells.
A key finding is the limited capacity of slarp(-) parasites to induce
long-lasting sterilizing immune responses, irrespective of their
ability to productively enter their final target cells. In particular,
immunization with low numbers of slarp(-) sporozoites did not
induce protection, in sharp contrast with P36p(-) parasites
generated in the same strain, which under similar conditions were
shown to fully protect immunized animals [46]. Although the poor
protective efficacy of SLARP-deficient parasites as compared to
other GAPs needs to be confirmed in side-by-side experiments, we
speculate that this failure to induce strong protection is due to the
lack of expression of antigens involved in protective immune
responses. The nature of protective antigens against Plasmodium LS
still remains elusive. T cell responses against the main sporozoite
surface protein, the circumsporozoite protein (CSP), are believed
to play an important role (reviewed in [47]). Nevertheless, two
recent studies using transgenic mice or parasites clearly demon-
strated that anti-CSP responses are dispensable for induction of
sterile protection [48,49], suggesting that additional antigens, most
likely LS antigens, are required [50]. We could show here that in
the absence of SLARP, LS development aborts before the
expression of the EXP1 antigen, which has been identified as a
protective antigen in P. yoelii [51]. We hypothesize that the early
and complete developmental arrest observed in SLARP-deficient
parasites causes a severe narrowing of their antigenic repertoire,
and consequently of the immune responses they elicit. Similar to
over-irradiated sporozoites, which are also inferior in eliciting
protective immunity [52], slarp(-) parasites are perfectly attenuat-
ed. Although they represent ideal candidates for a safe GAP-based
malaria vaccine high levels of protection may be very difficult to
achieve. However, such a tool, an attenuated, yet poorly protective
parasite, will be an important stepping stone towards the
identification of protective liver stage antigens and immune
effector cells. These studies can now be performed for the first
time in side-by-side comparisons with fully protective GAPs
generated in identical parasite strains [8,46]. This path may
ultimately lead to implementation of a safe metabolically active
whole organism vaccine and new subunit strategies for antimalaria
vaccine development.
Materials and Methods
Experimental animals, parasites and cell lines
Female NMRI mice, C57BL/6 mice and Sprague-Dawley (SD)
rats were from Charles River Laboratories. All animal work was
conducted in accordance with European regulations and approved
by the state authorities (Regierungspra ¨sidium Karlsruhe). We used
P. berghei ANKA clone 507 parasites, which constitutively express
the green fluorescent protein (GFP) [21]. HepG2 cells (ATCC HB-
8065) were cultured as described [53].
Plasmodium berghei transfection and genotypic analysis
For gene deletion, a 59 and a 39 fragment of PbSLARP were
amplified by PCR from P. berghei g e n o m i cD N A ,u s i n gp r i m e r s
SLARPrep1for (59-TCCCCGCGGCTAACGCATATACCTAT-
GATTCAGGACG-39), SLARPrep2rev (59-ATAAGAATGCGGC-
Table 3. P. berghei slarp(-) sporozoites elicit limited protective
responses in C57BL/6 mice against wild type sporozoite
challenge.
Immunization doses
a
Challenge dose
(days after last
boost)
b
No. protected/
No.
challenged
(%)
Prepatency
(days)
c
50,000/25,000/25,000 10,000 (d42) 5/5 (100%) NA
50,000/25,000/25,000 10,000 (d98) 2/5 (40%) (6,3)
10,000/10,000/10,000 10,000 (d23) 6/8 (75%) (5)
10,000/10,000/10,000 10,000 (d36) 1/4 (25%) (5,7)
1,000/1,000/1,000 10,000 (d36) 0/4 (0%) 4,25
Mosquito bites Mosquito bites (d42) 0/5 (0%) 4,4
None 10,000 0/8 (0%) 3,4
None Mosquito bites 0/3 (0%) 3,3
aC57BL/6 were immunized three times at two weeks intervals, with indicated
numbers of P. berghei slarp(-) sporozoites injected intravenously, or by
exposure to the bites of ten slarp(-) infected mosquitoes.
bImmunized mice were challenged by intravenous injection of 10,000 P. berghei
WT sporozoites or by exposure to the bites of five WT infected mosquitoes, as
indicated.
cNumber of days after sporozoite inoculation until detection of infected
erythrocytes by microscopic blood smear examination.
NA, not applicable.
doi:10.1371/journal.ppat.1000086.t003
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SLARPrep3for (59-CCCAAGCTTCTTCACAAATATAATCAAA-
CTTAGAACTGC-39)a n dSLARPrep4for (59-CGGGGTACC-
GAACTTCAAAATCATCCATATTATATCC-39). B3D+ plasmid
was obtained by inserting a 1214-bp fragment containing the 39
untranslated region of P. berghei dihydrofolate reductase/thymidylate synthase
(DHFR/TS)i n t oBamHI-EcoRI sites of the P. berghei targeting vector
b3D.DT^H.^D (provided by Dr. Andrew Waters), which contains
Toxoplasma gondii DHFR/TS as a selectable marker for resistance to
pyrimethamine. Cloning of P. berghei SLARP 59 and 39 fragments into
SacII-NotIa n dHindIII-KpnI sites, respectively, of B3D+ vector
resulted into SLARPrepB3D+ plasmid. Parasites were transfected
with SacII-KpnId i g e s t e dSLARPrepB3D+ construct, using the
NucleofectorH device (Amaxa GmbH) as described [21], injected
intravenously into naı ¨ve NMRI mice, and selected by pyrimethamine
treatment in the drinking water. Clonal parasite populations were
obtained by limiting dilution series and intravenous injection of one
parasite in 15 recipient NMRI mice. Genotyping of WT and slarp(-)
parasites was performed by PCR on parasite genomic DNA using
primers specific for the wt locus (SLARPwtfor, 59-GAGACATAT-
CAAATAATTACTACATACCACC-39; SLARPwtrev, 59-GGGG-
TTCATAATTATATTTTCATTAGGGTCC-39), the 5’ (SLAR-
Preptest1for, 59-TCCCCGCGGCTAAAGTTCTCTATCGAA-
TATAATATATACG-39;U T R r e v ,5 9-AATTCCGGTGTGAAA-
TACCGCACAGATGCG-39)a n dt h e3 ’( T g P R O ,5 9-CGCATTA-
TATGAGTTCATTTTACACAATCC-39; SLARPreptest2rev, 59-
CGGGGTACCCACACGAATGTGTATGCTTATGAAGAT-
GG-39) recombination events.
C-terminal fluorescent tagging
For fusion of the red fluorescent protein mCherry [20] to the C-
terminus of SLARP, a 720-bp fragment corresponding to
mCherry was first cloned into SpeI-BamHI sites of B3D+ plasmid,
resulting in B3D+mCherry vector. A PCR fragment correspond-
ing to the last 2500-bp of PbSLARP was amplified with primers
SLARPtagfor (59-ATAAGAATGCGGCCGCTATGAGAAATA-
CTGGGAATACCATTGAAGG-39) and SLARPtagrev (59-GGA-
CTAGTATAAAATAAGAATCGATTCATTATTTCAAAATT-
TATATGG-39), and cloned into NotI-SpeI sites of B3D+mCherry,
resulting in the SLARPtagging construct. This targeting plasmid
was linearized with HpaI and transfected as described above.
Naı ¨ve recipient mice were injected with transfected parasites and
treated with pyrimethamine to select for recombinant PbSLARP/
mCherry parasites. Integration of the construct in selected
parasites was confirmed by PCR on genomic DNA using specific
primer combinations. Expression of the SLARP/mCherry fusion
protein was analyzed through direct detection of the red
fluorescence of mCherry by confocal microscopy.
Reverse transcriptase-PCR
Total RNA was purified from sporozoites, infected HepG2 cells
or infected erythrocytes using the RNeasy kit (Qiagen). Reverse
transcription was performed using the RETROscript kit (Ambion).
cDNA was used as template for PCR amplification with primers
specific for P. berghei SLARP (SLARPcDNAfor, 59-TCCCCGCGGA-
CAAGTTCAACAATCTTTTAATCACAGCGC-39; SLARPcD-
NArev, 59-ATAAGAATGCGGCCGCACACGAATGTGTATG-
CTTATGAAGATGGGG-39), TRAP (TRAPcDNAfor, 59-CCC-
GGATCCATGAAGCTCTTAGGAAATAG-39; TRAPcDNArev,
59-GTGTGGATCCTTCCTGACAAACTTTAGAAAG-39), UIS4
(UIS4cDNAfor, 59-ACCCATTGATGAGACAAACGATTCAA-
AACC-39; UIS4cDNArev, 59-TCCATGTTATAAACGTTATT-
TCCTTCACCC-39)o rGAPDH (GAPDHcDNAfor, 59-ATGG-
CAATAACAAAAGTCGGAATTAATGG-39; GAPDHcDNArev,
59-TGTGGATAGCCAAATCTAAAAGACGG-39).
Real time quantitative RT-PCR
Real time qPCR was performed on cDNA preparations using
the ABI 7500 sequence detection system and Power SYBRH
Green PCR Master Mix (Applied Biosystems), according to the
manufacturer’s instructions. Three independent cDNA samples
were tested for each population. qPCR was performed in
triplicates, with 1 cycle of 95uC for 15 min, followed by 40 cycles
of 95uC for 15 s, 55uC for 15 s, and 60uC for 45 s. Standard
curves were generated for all primers using WT cDNA serial
dilutions and gave amplification efficiencies of 90–100%. Data
were analyzed with the SDS 1.3.1 software (Applied Biosystems).
Relative transcript abundance was determined using the 2
2DDCt
method (User Bulletin 2, ABI). Expression data were normalized
using the GFP gene. For analysis of HSP70, UIS3, UIS4, TRAP,
AMA1 and SPECT expression by RT-qPCR, we used the same
primers as reported by Amino et al. [24]. Additional primers
include: GFP forward, 59-GATGGAAGCGTTCAACTAGCA-
GACC-39; GFP reverse, 59-AGCTGTTACAAACTCAAGAAG-
GACC-39;GAPDH forward, 59-AATTAAAGAAGCATCT-
GAGGGTCCAC-39; GAPDH reverse, 59-TTGAATATCCC-
CATTCATTGTCATACC-39; EXP1 forward, 59-AGGGAAGA-
CATCCATTCCAAATTGG-39; EXP1 reverse, 59-TGAA-
GATTTGGCATGTTAAGTGGTG-39.
Sporozoite infectivity in vivo
SD rats or C57BL/6 mice were injected intravenously with
100 ml of sporozoite suspension of WT or slarp(-) parasites isolated
from the salivary glands of infected Anopheles stephensi mosquitoes,
or exposed to 5–10 infected mosquito bites, as indicated. Infection
was then monitored daily by examination of Giemsa-stained blood
smears. The delay of patency was defined as the time before
detection of at least one erythrocytic stage in the smears.
Phenotypic analysis of mutant parasites in vitro
For analysis of sporozoite cell traversal, HepG2 cells were
incubated 3 hours at 37uC with sporozoites (5610
4) in the
presence of 0.5 mg/ml fluorescein-conjugated dextran (Molecular
Probes) [23]. Cells were then trypsinized and washed to remove
extracellular sporozoites and dextran, and either analyzed by
FACS to determine the percentage of dextran-positive cells, or
plated in 8-chamber plastic Lab-Tek slides and further cultured at
least 3 hours before analysis by fluorescence microscopy. To
analyze productive infection and LS development, infected
HepG2 cultures in Lab-Teks were incubated for 6–72 hours
post-infection before analysis by immunofluorescence using
primary antibodies against P. berghei CSP [54], HSP-70 [55],
UIS4 [6], or EXP1 [19] as indicated, and appropriate secondary
antibodies (Molecular probes). Hoechst 33342 (Molecular Probes)
was used to stain nuclei. Cholesterol staining with filipin (Sigma)
was performed as described [56]. Images were acquired on a Zeiss
LSM510 confocal system (Zeiss, Germany) equipped with visible
and UV laser lines, and processed with Adobe Photoshop software
(Adobe Systems Inc.).
Immunization and sporozoite challenge experiments
C57BL/6 mice were immunized three times at 2 weeks intervals
with slarp(-) sporozoites injected intravenously. Animals were
immunized by intravenous injection of 1,000, 10,000 or 50,000
sporozoites, followed by two boosts of 1,000, 10,000 or 25,000,
respectively. For immunization through mosquito bites, mice were
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weeks intervals. Immunized mice were challenged at least 3 weeks
after the last boost by intravenous injection of 10,000 P. berghei
ANKA WT sporozoites or exposure to the bites of 5 infected
mosquitoes. Infection was monitored daily by examination of
Giemsa-stained blood smears until day 21 post-challenge. Non-
immunized C57BL/6 mice were included in all challenge
experiments to control WT sporozoite infectivity.
Accession numbers
The nucleotide sequences reported in this paper have been
submitted to the Genbank database with the accession numbers
EU579524 and EU579525.
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